Company Filing History:
Years Active: 2017
Title: Dae Young Hur: Innovator in Dendritic Cell Maturation and Neovascular Disease Models
Introduction
Dae Young Hur is a prominent inventor based in Busan, South Korea. He has made significant contributions to the field of biomedical research, particularly in the development of innovative methods for dendritic cell maturation and models for neovascular diseases. With a total of 2 patents, his work is paving the way for advancements in medical treatments.
Latest Patents
One of Dae Young Hur's latest patents is titled "Composition containing complex cytokines derived from EBV-infected B cells for inducing the maturation of dendritic cells." This invention presents a composition that includes complex cytokines generated by the stimulation of EBV-infected B cells. Notably, this method shortens the dendritic cell maturation process from the conventional 7 days to just 2 days, making it a more economically advantageous and effective approach.
Another significant patent is "Cell model for neovascular diseases using EBV-infected human corneal epithelial cells." This invention relates to a cell model designed for diseases associated with corneal neovascularization. The method involves infecting human corneal epithelial cells (HCECs) with EBV, culturing the infected cells, and determining the infection status. This model provides a valuable tool for screening diseases related to corneal neovascularization.
Career Highlights
Dae Young Hur is affiliated with the Inje University Industry-Academic Cooperation Foundation, where he continues to engage in groundbreaking research. His work is characterized by a commitment to advancing scientific knowledge and improving medical outcomes.
Collaborations
Dae Young Hur collaborates with notable colleagues, including Ga Bin Park and Yeong Seok Kim. Their combined expertise contributes to the innovative research being conducted at their institution.
Conclusion
Dae Young Hur's contributions to the fields of dendritic cell maturation and neovascular disease modeling highlight his role as a leading inventor in biomedical research. His patents reflect a dedication to improving medical practices and outcomes.